| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.54 | 0.07 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.43 | 0.02 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.22 | 7e-05 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.21 | 9e-05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |